Trump’s ACA Orders – One’s big news, the other’s just political fluff

President Trump announced two major policy changes yesterday; one will do little to affect healthcare markets and insurance, the other will have a drastic and almost immediate impact. Cost Sharing Reimbursement payments help those making less than 250% of the … Continue reading Trump’s ACA Orders – One’s big news, the other’s just political fluff

Read More...

There’s no BIG problem in work comp pharmacy – and that’s scary.

In the fourteen years I’ve been surveying work comp payers on their views on pharmacy, I’ve never seen so little consensus among respondents on emerging issues. In past years compounds, physician dispensing, opioids, price inflation, and new drug introductions have … Continue reading There’s no BIG problem in work comp pharmacy – and that’s scary.

Read More...

Opioid Exceptionalism – why these drugs are different than all others

Greetings – David Deitz here. Joe has kindly offered to let me provide a guest post on the latest report on the opioid epidemic from the National Academy of Sciences, Engineering and Medicine (NASEM). The report is available here. It’s … Continue reading Opioid Exceptionalism – why these drugs are different than all others

Read More...